Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Perspective Therapeutics (CATX) Equity Ratio (2016 - 2025)

Perspective Therapeutics' Equity Ratio history spans 15 years, with the latest figure at 0.82 for Q3 2025.

  • For Q3 2025, Equity Ratio fell 2.17% year-over-year to 0.82; the TTM value through Sep 2025 reached 0.82, down 2.17%, while the annual FY2024 figure was 0.85, 10.96% up from the prior year.
  • Equity Ratio for Q3 2025 was 0.82 at Perspective Therapeutics, down from 0.86 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.96 in Q4 2021 and bottomed at 0.77 in Q4 2023.
  • The 5-year median for Equity Ratio is 0.9 (2023), against an average of 0.9.
  • The largest annual shift saw Equity Ratio soared 50.74% in 2021 before it decreased 18.35% in 2023.
  • A 5-year view of Equity Ratio shows it stood at 0.96 in 2021, then dropped by 1.76% to 0.94 in 2022, then decreased by 18.35% to 0.77 in 2023, then increased by 10.96% to 0.85 in 2024, then dropped by 3.59% to 0.82 in 2025.
  • Per Business Quant, the three most recent readings for CATX's Equity Ratio are 0.82 (Q3 2025), 0.86 (Q2 2025), and 0.86 (Q1 2025).